Figure 3. Forest plots of the included studies comparing major bleeding (a) and symptomatic venous thromboembolism (b) in patients who received rivaroxaban and those who received enoxaparin.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.